FDA Approves Apalutamide (Erleada); the first treatment for non-metastatic castration-resistant prostate cancer (READ MORE HERE).
A Nano-Structured Platform for Enhanced Detection of..
University of California, Los Angeles
Dr. Roychowdhury works to underline and identify..
Sameek Roychowdhury, MD, PhD:
The Ohio State University
Arul Chinnaiyan, MD, PhD and Ken Pienta, MD
The success of next-generation androgen receptor (AR)..
Dana Rathkopf, MD:
Memorial Sloan-Kettering Cancer Center
Howard Scher and MD Neal Rosen, MD, PhD
Improving the Therapeutic Window of Radiation Therapy..
Professor, Department of Dermatology & Cutaneous Biology
Jefferson Medical College-Thomas Jefferson University
Dr. Redmond earned a BS in Biology..
William L. Redmond, PhD:
Providence Portland Medical Center – Portland, OR
Dr. Raj earned a BS degree in..
Ganesh Raj, MD:
UT Southwestern Medical Center – Dallas, TX
The role of recurrent gene fusion SDK1-AMACR..
Shancheng Ren, MD, PhD:
Shanghai Changhai Hospital
Yinghao Sun, MD, PhD
Low vitamin D levels in blood have..
Jennifer Rider, ScD:
Harvard School of Public Health
Lorelei Mucci, ScD and Myles Brown, MD
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer
Dr. Rubin and colleagues have identified a..
Mark A. Rubin, MD –:
Weill Cornell Medical College
Recurrent SPOP Mutations in Prostate Cancer: Characterization of a Potentially Targetable Sub-class of Prostate Cancer
Pengbo Zhou, PhD; Hao Wu, PhD; Francesca Demichelis, PhD
The Wonderful Company LLC
International Financial Company